A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial

Patients with multiple myeloma are generally older and vary in fitness levels, which may influence the clinical benefit of treatment. Patients from the large, phase 3 FIRST trial in newly diagnosed multiple myeloma (NDMM) were retrospectively investigated to determine outcomes based on frailty using...

Descripción completa

Detalles Bibliográficos
Autores principales: Facon, Thierry, Dimopoulos, Meletios A., Meuleman, Nathalie, Belch, Andrew, Mohty, Mohamad, Chen, Wen-Ming, Kim, Kihyun, Zamagni, Elena, Rodriguez-Otero, Paula, Renwick, William, Rose, Christian, Tempescul, Adrian, Boyle, Eileen, Manier, Salomon, Attal, Michel, Moreau, Philippe, Macro, Margaret, Leleu, Xavier, Lorraine Chretien, Marie, Ludwig, Heinz, Guo, Shien, Sturniolo, Michael, Tinel, Antoine, Silvia Monzini, Mara, Costa, Bruno, Houck, Vanessa, Hulin, Cyrille, Yves Mary, Jean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214253/
https://www.ncbi.nlm.nih.gov/pubmed/31427722
http://dx.doi.org/10.1038/s41375-019-0539-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214253/
https://www.ncbi.nlm.nih.gov/pubmed/31427722
http://dx.doi.org/10.1038/s41375-019-0539-0

Ejemplares similares